OligoConnect: Linking Science, Innovation, and Therapeutics (Day 1)
Agilent: OligoConnect: Linking Science, Innovation, and Therapeutics
Join Us For This Innovative Oligo Virtual Event
Join some or all of the sessions over 13 & 14 March.
In recent years a renewed interest in synthetic oligonucleotides has been piqued due to their potential in biochemical research and for therapeutic applications. This popularity has meant a growing need to develop robust approaches for analysis and purification of oligos, alongside an increased understanding of this class of compounds.
Across 2 days this educational virtual event will share key learnings around the analysis of synthetic oligonucleotides, providing expert insights from research discovery to production QA/QC. We invite you to join along with other scientists in this important field to revisit oligo fundamentals, discover tips and tricks, ask questions to experts, and discuss recent innovations in this fast-moving environment.
Agenda:
Day 1
10:00 - Quality Assessment Challenges and Opportunities in Oligonucleotide Therapeutics
- Dr Ravi Shah, Associate Professor, National Institute of Pharmaceutical Education and Research, Ahmedabad
10:45 - Analysis & Purification of Oligonucleotides: Method Development Optimization from Characterization to Purification
- Giorgio Ferlat, EMEAI IDO Product Specialist, Agilent Technologies
11:30 - Accelerate your Oligonucleotide Analysis: Optimized LCMS Workflows for Quality Assessment
- Ashish Pargaonkar, CoE Manager/Applications Engineer, Agilent Technologies